These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25356031)

  • 41. [What is motility all about?].
    Beglinger Ch
    Ther Umsch; 2007 Apr; 64(4):191-3. PubMed ID: 17663203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.
    Lopetuso LR; Scaldaferri F; Bruno G; Petito V; Franceschi F; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2015; 19(6):1068-76. PubMed ID: 25855934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Metabolic disturbances in liver cirrhosis (part 1)--hepatic osteopathy and malnutrition].
    Gundling F; Seidl H; Löffler N; Strassen I; Schepp W
    Dtsch Med Wochenschr; 2009 Nov; 134(48):2461-4. PubMed ID: 19924612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enteric neuropathy in diabetes: Implications for gastrointestinal function.
    Abdalla MMI
    World J Gastroenterol; 2024 Jun; 30(22):2852-2865. PubMed ID: 38947292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Are disturbances of small intestinal motility associated with hyperglucagonemia in patients with liver cirrhosis?].
    Chesta J; Generini G; Antezana C; Defilippi C
    Rev Med Chil; 1992 Sep; 120(9):998-1002. PubMed ID: 1340993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association between enteric bacterial overgrowth and gastrointestinal motility after subtotal liver resection or portal vein obstruction in rats.
    Wang XD; Guo WD; Wang Q; Andersson R; Ekblad E; Soltesz V; Bengmark S
    Eur J Surg; 1994 Mar; 160(3):153-60. PubMed ID: 7516192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review article: gastric emptying in functional gastrointestinal disorders.
    Quigley EM
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():56-60. PubMed ID: 15521856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The influence of splenic artery ligature on the severity of portal gastropathy in patients with hepatic cirrhosis].
    Rusyn VI; Butsko IeS; Rusyn AV; Rumiantsev KIe; Kovach VV
    Klin Khir; 2003 Oct; (10):50-1. PubMed ID: 14730881
    [No Abstract]   [Full Text] [Related]  

  • 50. Gut flora and bacterial translocation in chronic liver disease.
    Almeida J; Galhenage S; Yu J; Kurtovic J; Riordan SM
    World J Gastroenterol; 2006 Mar; 12(10):1493-502. PubMed ID: 16570339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered GI motility in critically Ill patients: current understanding of pathophysiology, clinical impact, and diagnostic approach.
    Ukleja A
    Nutr Clin Pract; 2010 Feb; 25(1):16-25. PubMed ID: 20130154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current concepts in functional gastrointestinal disorders.
    Kovacic K
    Curr Opin Pediatr; 2015 Oct; 27(5):619-24. PubMed ID: 26208234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats.
    Zhang HL; Yu LX; Yang W; Tang L; Lin Y; Wu H; Zhai B; Tan YX; Shan L; Liu Q; Chen HY; Dai RY; Qiu BJ; He YQ; Wang C; Zheng LY; Li YQ; Wu FQ; Li Z; Yan HX; Wang HY
    J Hepatol; 2012 Oct; 57(4):803-12. PubMed ID: 22727732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
    Reiberger T; Ferlitsch A; Payer BA; Mandorfer M; Heinisch BB; Hayden H; Lammert F; Trauner M; Peck-Radosavljevic M; Vogelsang H;
    J Hepatol; 2013 May; 58(5):911-21. PubMed ID: 23262249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Gastrointestinal complications of liver cirrhosis].
    Yin XR; Chen DF
    Zhonghua Gan Zang Bing Za Zhi; 2020 May; 28(5):377-380. PubMed ID: 32536051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diabetic neuropathy in the gut: pathogenesis and diagnosis.
    Azpiroz F; Malagelada C
    Diabetologia; 2016 Mar; 59(3):404-8. PubMed ID: 26643877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastrointestinal motility disorders in patients with anorexia nervosa - a review of the literature.
    Weterle-Smolińska KA; Banasiuk M; Dziekiewicz M; Ciastoń M; Jagielska G; Banaszkiewicz A
    Psychiatr Pol; 2015; 49(4):721-9. PubMed ID: 26488348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonruminant Nutrition Symposium: Involvement of gut neural and endocrine systems in pathological disorders of the digestive tract.
    Furness JB; Poole DP
    J Anim Sci; 2012 Apr; 90(4):1203-12. PubMed ID: 22178854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients.
    Montano-Loza AJ
    Minerva Gastroenterol Dietol; 2013 Jun; 59(2):173-86. PubMed ID: 23831908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The gut response to food: a physiological perspective on food-induced gastrointestinal symptoms - it's not all allergy and intolerance!
    Quigley EM
    Curr Opin Gastroenterol; 2017 Mar; 33(2):99-101. PubMed ID: 28146447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.